Jafib-Ep

JAFIB-EP serves the needs of the needs of a diverse global EP community. The Journal provides a forum for communicating original and innovative research findings that have relevance and a deeper understanding of the pathophysiology of cardiac rhythm disorders to improve the treatment, quality of life and survival of millions of patients across the globe. JAFIB-EP articles cover the breadth of EP conditions. These include Atrial Fibrillation (AF), Ventricular Arrhythmias (VA) and conduction system abnormalities that contribute to significant patient morbidity and mortality, through stroke, heart failure, sudden cardiac arrest and more. EP is a dynamic field that, with continued discovery and innovation, has helped bring many therapies from bench to bedside for clinical application to patients. JAFIB-EP offers a free publication platform. The Journal is Open Access with no fees to authors. We publish 6 times a year, along with special editions.